Upholding the T cell immune-regulatory function of CD31 inhibits the formation of T/B immunological synapses invitro and attenuates the development of experimental autoimmune arthritis in vivo

Journal of Autoimmunity

Volumn 56, Issue , 2015, Pages 23-33

  Clement, Marc ^a,b,c   Fornasa, Giulia ^a,b,c   Loyau, Stéphane ^a,b,c   Morvan, Marion ^a,b,c   Andreata, Francesco ^a,b,c   Guedj, Kevin ^a,b,c   Khallou Laschet, Jamila ^a,b,c   Larghi, Paola ^d   Le Roux, Delphine ^b,e,f   Bismuth, Georges ^b,e,f   Chiocchia, Gilles ^g,h,i   Hivroz, Claire ^d   Newman, Debra K ^j   Nicoletti, Antonino ^a,b,c   Caligiuri, Giuseppina ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c P R E S Paris Sorbonne Cité   (France)

^d PSL RESEARCH UNIVERSITY   (France)

^e INSTITUT COCHIN   (France)

^f CNRS   (France)

^g INSERM U 987   (France)

^h Labex Inflamex   (France)

ⁱ LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^j BLOOD RESEARCH INSTITUTE   (United States)

more..

Author keywords

Autoimmune arthritis; CD31; Immunological synapse; Inhibitory receptors; ITIM; T lymphocytes

Indexed keywords

ALLOCHRYSINE; CD31 ANTIGEN; CELECOXIB; ETANERCEPT; GOLD SALT; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PARACETAMOL; PREDNISONE; PROTEIN KINASE ZAP 70; PROTEIN TYROSINE PHOSPHATASE SHP 2;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; BINDING SITE; CELL SURFACE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL SYNAPSE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; JOINT BIOPSY; MIDDLE AGED; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; AUTOIMMUNE DISEASES; B LYMPHOCYTE; BIOPSY; CELL COMMUNICATION; CELL LINE; DRUG EFFECTS; EXPERIMENTAL ARTHRITIS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SYNOVIUM; T LYMPHOCYTE SUBPOPULATION;

AGED; ANIMALS; ANTIGENS, CD31; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; BIOPSY; CELL COMMUNICATION; CELL LINE; FEMALE; HUMANS; IMMUNOLOGICAL SYNAPSES; LYMPHOCYTE ACTIVATION; MICE; MIDDLE AGED; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; T-LYMPHOCYTE SUBSETS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 84920288556     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.09.002     Document Type: Article

References (43)

1. Chen L., Flies D.B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 2013, 13:227-242.
2. Newman P.J. Switched at birth: a new family for PECAM-1. JClin Invest 1999, 103:5-9.
3. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science 2000, 290:84-89.
4. Stockinger H., Gadd S.J., Eher R., Majdic O., Schreiber W., Kasinrerk W., et al. Molecular characterization and functional analysis of the leukocyte surface protein CD31. JImmunol 1990, 145:3889-3897.
5. Stockinger H., Schreiber W., Majdic O., Holter W., Maurer D., Knapp W. Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family. Immunology 1992, 75:53-58.
6. Newman P.J., Berndt M.C., Gorski J., White G.C., Lyman S., Paddock C., et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990, 247:1219-1222.
7. Newton J.P., Buckley C.D., Jones E.Y., Simmons D.L. Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. JBiol Chem 1997, 272:20555-20563.
8. Newman P.J., Newman D.K. Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 2003, 23:953-964.
9. Newman D.K., Hamilton C., Newman P.J. Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood 2001, 97:2351-2357.
10. Tourret M., Guegan S., Chemin K., Dogniaux S., Miro F., Bohineust A., et al. Tcell polarity at the immunological synapse is required for CD154-dependent IL-12 secretion by dendritic cells. JImmunol 2010, 185:6809-6818.
11. van Kooten C., Banchereau J. CD40-CD40 ligand. JLeukoc Biol 2000, 67:2-17.
12. Takemura S., Klimiuk P.A., Braun A., Goronzy J.J., Weyand C.M. Tcell activation in rheumatoid synovium is B cell dependent. JImmunol 2001, 167:4710-4718.
13. Ma L., Mauro C., Cornish G.H., Chai J.G., Coe D., Fu H., et al. Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance. Proc Natl Acad Sci U S A 2010, 107:19461-19466.
14. Wilkinson R., Lyons A.B., Roberts D., Wong M.X., Bartley P.A., Jackson D.E. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease. Blood 2002, 100:184-193.
15. Tada Y., Koarada S., Morito F., Ushiyama O., Haruta Y., Kanegae F., et al. Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1. Arthritis Rheum 2003, 48:3280-3290.
16. Wong M.X., Hayball J.D., Hogarth P.M., Jackson D.E. The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis. JClin Immunol 2005, 25:19-28.
17. Marelli-Berg F.M., Clement M., Mauro C., Caligiuri G. An immunologist's guide to CD31 function in T-cells. JCell Sci 2013, 126:2343-2352.
18. Newton-Nash D.K., Newman P.J. Anew role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. JImmunol 1999, 163:682-688.
19. Munoz P., Mittelbrunn M., de la Fuente H., Perez-Martinez M., Garcia-Perez A., Ariza-Veguillas A., et al. Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse. Blood 2008, 111:3653-3664.
20. Fornasa G., Groyer E., Clement M., Dimitrov J., Compain C., Gaston A.T., et al. TCR stimulation drives cleavage and shedding of the ITIM receptor CD31. JImmunol 2010, 184:5485-5492.
21. Brown S., Heinisch I., Ross E., Shaw K., Buckley C.D., Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature 2002, 418:200-203.
22. Brand D.D., Latham K.A., Rosloniec E.F. Collagen-induced arthritis. Nat Protoc 2007, 2:1269-1275.
23. Groyer E., Nicoletti A., Ait-Oufella H., Khallou-Laschet J., Varthaman A., Gaston A.T., et al. Atheroprotective effect of CD31 receptor globulin through enrichment of circulating regulatory T-cells. JAm Coll Cardiol 2007, 50:344-350.
24. Pathak M.K., Yi T. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. JImmunol 2001, 167:3391-3397.
25. Frearson J.A., Alexander D.R. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells. JExp Med 1998, 187:1417-1426.
26. Martin F., Chan A.C. Pathogenic roles of B cells in human autoimmunity; insights from the clinic. Immunity 2004, 20:517-527.
27. Aarvak T., Natvig J.B. Cell-cell interactions in synovitis: antigen presenting cells and T cell interaction in rheumatoid arthritis. Arthritis Res 2001, 3:13-17.
28. Guery L., Chiocchia G., Batteux F., Boissier M.C., Fournier C. Collagen II-pulsed antigen-presenting cells genetically modified to secrete IL-4 down-regulate collagen-induced arthritis. Gene Ther 2001, 8:1855-1862.
29. Allenspach E.J., Cullinan P., Tong J., Tang Q., Tesciuba A.G., Cannon J.L., et al. ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. Immunity 2001, 15:739-750.
30. Freiberg B.A., Kupfer H., Maslanik W., Delli J., Kappler J., Zaller D.M., et al. Staging and resetting T cell activation in SMACs. Nat Immunol 2002, 3:911-917.
31. Lin J., Weiss A. The tyrosine phosphatase CD148 is excluded from the immunologic synapse and down-regulates prolonged T cell signaling. JCell Biol 2003, 162:673-682.
32. Cordoba S.P., Choudhuri K., Zhang H., Bridge M., Basat A.B., Dustin M.L., et al. The large ectodomains of CD45 and CD148 regulate their segregation from and inhibition of ligated T-cell receptor. Blood 2013, 121:4295-4302.
33. Tong J., Allenspach E.J., Takahashi S.M., Mody P.D., Park C., Burkhardt J.K., et al. CD43 regulation of T cell activation is not through steric inhibition of T cell-APC interactions but through an intracellular mechanism. JExp Med 2004, 199:1277-1283.
34. Bazil V., Strominger J.L. CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes. Proc Natl Acad Sci U S A 1993, 90:3792-3796.
35. Jung T.M., Dailey M.O. Rapid modulation of homing receptors (gp90MEL-14) induced by activators of protein kinase C. Receptor shedding due to accelerated proteolytic cleavage at the cell surface. JImmunol 1990, 144:3130-3136.
36. Smalley D.M., Ley K. L-selectin: mechanisms and physiological significance of ectodomain cleavage. JCell Mol Med 2005, 9:255-266.
37. Garton K.J., Gough P.J., Raines E.W. Emerging roles for ectodomain shedding in the regulation of inflammatory responses. JLeukoc Biol 2006, 79:1105-1116.
38. Ilan N., Mohsenin A., Cheung L., Madri J.A. PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. FASEB J 2001, 15:362-372.
39. Ishikaw J., Okada Y., Bird I.N., Jasani B., Spragg J.H., Yamada T. Use of anti-platelet-endothelial cell adhesion molecule-1 antibody in the control of disease progression in established collagen-induced arthritis in DBA/1J mice. Jpn J Pharmacol 2002, 88:332-340.
40. Dasgupta B., Chew T., deRoche A., Muller W.A. Blocking platelet/endothelial cell adhesion molecule 1 (PECAM) inhibits disease progression and prevents joint erosion in established collagen antibody-induced arthritis. Exp Mol Pathol 2010, 88:210-215.
41. Chen Y., Schlegel P.G., Tran N., Thompson D., Zehnder J.L., Chao N.J. Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease. Blood 1997, 89:1452-1459.
42. Fornasa G., Clement M., Groyer E., Gaston A.T., Khallou-Laschet J., Morvan M., et al. ACD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation. Cardiovasc Res 2012, 94:30-37.
43. Rui Y., Liu X., Li N., Jiang Y., Chen G., Cao X., et al. PECAM-1 ligation negatively regulates TLR4 signaling in macrophages. JImmunol 2007, 179:7344-7351.